Results 71 to 80 of about 24,874 (200)

Neuroprotection against vascular dementia after acupuncture combined with donepezil hydrochloride: P300 event related potential

open access: yesNeural Regeneration Research, 2016
Acupuncture can be used to treat various nervous system diseases. Here, 168 vascular dementia patients were orally administered donepezil hydrochloride alone (5 mg/day, once a day for 56 days), or combined with acupuncture at Shenting (DU24), Tianzhu ...
Qiang Liu   +5 more
doaj   +1 more source

Neurodegenerative Diseases: Epidemiology, Risk Factors, Classification, Pathophysiology, Clinical Features, Diagnosis, and Therapeutic Strategies

open access: yesMedComm, Volume 7, Issue 11, November 2026.
Neurodegenerative diseases share convergent risk architectures and pathological mechanisms, yet diverge in selective vulnerability, clinical presentation, and therapeutic responsiveness. This review integrates cross‐disease epidemiology, pathophysiology, diagnosis, and treatment, highlighting the transition from symptomatic care toward biomarker‐guided
Zimeng He   +4 more
wiley   +1 more source

Clinical Observation on Basal Ganglia Aphasia after Stroke Treated by Donepezil

open access: yes康复学报, 2015
Objective:To evaluate the curative effect of donepezil on basal ganglia aphasia after stroke.Methods:A total of 37 patients with basal ganglia aphasia after stroke were randomly assigned to donepezil group (n=19) and control group (n=18).
Xi CHENG   +5 more
doaj  

Switching from Oral Cholinesterase Inhibitors to a Transdermal Donepezil Patch Attenuated Gastrointestinal Symptoms and Allowed Treatment Continuation in Three Patients with Alzheimer’s Disease in Clinical Settings

open access: yesBrain Sciences
Background: Cholinesterase inhibitors (ChEIs) are commonly prescribed for the treatment of Alzheimer’s disease (AD) and achieve long-term benefits for cognition and survival in real-world settings.
Yumiko Motoi, Nobuo Sanjo
doaj   +1 more source

Alzheimer's Disease: Mechanisms and Therapeutic Advances

open access: yesMedComm, Volume 7, Issue 11, November 2026.
Alzheimer's disease involves Aβ/tau aggregation, neuroinflammation, BBB leakage, gut–brain dysfunction, and mitochondrial damage, causing neuronal loss. Nanodelivery enables combined small‐molecule and targeted therapies. Disease‐modifying biologics/chemicals, including anti‐Aβ antibodies, raise safety and access concerns. Exercise, cognitive training,
Gaoshuang Fu   +4 more
wiley   +1 more source

Violent behavior associated with donepezil

open access: yes, 1998
Reports a case of violent behavior following the commencement of donepezil in a 76-yr-old male with a 2-yr history of cognitive impairment, diagnosed as Alzheimer's disease. Five days after donepezil, 5 mg daily, the S became paranoid, and beat his wife.
Pinner, Gill, Bouman, Walter P.
core   +1 more source

Efficacy and safety of pharmacological interventions for the treatment of cocaine use disorder: A systematic review and network meta‐analysis

open access: yesAddiction, Volume 121, Issue 11, Page 2897-2958, November 2026.
Abstract Background and aims Cocaine use disorder (CUD) is an increasingly widespread concern worldwide. Various pharmacological treatments have been investigated for CUD, but their efficacy remains unclear, and none have been licensed for treatment.
Craig Paterson   +13 more
wiley   +1 more source

Evaluation of the antioxidant activity of donepezil - in vitro study

open access: yesNational Journal of Physiology, Pharmacy and Pharmacology, 2019
Background: Donepezil is a cerebroselective anticholinesterase which is majorly used for memory enhancement in Alzheimer’s disease (AD). The main action is through increasing central cholinergic neurotransmission but also indicated that it protects ...
Vinay Munishamappa   +3 more
doaj   +1 more source

Clinical Trajectory of Late‐Onset Delusional Disorder Toward Evolving Dementia With Lewy Bodies

open access: yesPsychogeriatrics, Volume 26, Issue 6, November 2026.
ABSTRACT Recent clinical observations indicate that late‐onset psychosis can precede the onset of dementia with Lewy bodies (DLB). However, its longitudinal clinical trajectory remains poorly understood. Delusional disorder (DD) in older adults is relatively uncommon and poor insight frequently leads to refusal of psychiatric care, limiting available ...
Hiroshige Fujishiro   +7 more
wiley   +1 more source

Modulatory effect of caffeic acid on cholinesterases inhibitory properties of donepezil

open access: yes, 2017
BackgroundDonepezil hydrochloride commonly used in the management of Alzheimer’s disease (AD), exhibiting its inhibitory effects on acetylcholinesterase and butyrylcholinesterase activity thereby enhance cognitive function.
Ganiyu Oboh, Odunayo Michael Agunloye
core   +1 more source

Home - About - Disclaimer - Privacy